.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Predict branded drug patent expiration
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
Accenture
McKinsey
Teva
Chubb
Citi
Express Scripts
Federal Trade Commission
Julphar
Argus Health

Generated: June 27, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 075442

« Back to Dashboard
NDA 075442 describes FLECAINIDE ACETATE, which is a drug marketed by Sun Pharm Inds Ltd, Idt Australia Ltd, Amneal Pharm, Apotex Inc, West-ward Pharms Int, and Ani Pharms Inc, and is included in six NDAs. It is available from thirteen suppliers. Additional details are available on the FLECAINIDE ACETATE profile page.

The generic ingredient in FLECAINIDE ACETATE is flecainide acetate. There are nine drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the flecainide acetate profile page.

Summary for NDA: 075442

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 075442

Suppliers and Packaging for NDA: 075442

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
FLECAINIDE ACETATE
flecainide acetate
TABLET;ORAL 075442 ANDA AvKARE, Inc. 42291-293 42291-293-01 100 TABLET in 1 BOTTLE (42291-293-01)
FLECAINIDE ACETATE
flecainide acetate
TABLET;ORAL 075442 ANDA AvKARE, Inc. 42291-294 42291-294-01 100 TABLET in 1 BOTTLE (42291-294-01)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength50MG
Approval Date:Jul 31, 2001TE:ABRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength100MG
Approval Date:Jul 31, 2001TE:ABRLD:No

Summary for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength150MG
Approval Date:Jul 31, 2001TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Argus Health
Baxter
Novartis
Fuji
Merck
Cerilliant
Accenture
Cantor Fitzgerald
AstraZeneca
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot